HomeInsightsPE

Mangalam Drugs And Organics Ltd PE Ratio

Mangalam Drugs And Organics Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 6, 2024)

stocks purchased

0.5 K

Stocks Traded

(Dec 6, 2024)

Last Updated on: Dec 08, 2024

Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

PE

20.4

Last updated on: Dec 08, 2024

Key Highlights

  • The P/E Ratio of Mangalam Drugs and Organics Ltd is 20.4 as of 08 Dec 9.00 AM .
  • The P/E Ratio of Mangalam Drugs and Organics Ltd is 0 as of March 2024 .
  • The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 121 as of 06 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.
Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

PE

-

Last updated on: Invalid Date

Company Fundamentals for Mangalam Drugs and Organics Ltd

No data available

Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

Share Price

₹ 121

-0.40 (-0.33%)

stock direction

Last updated on: Dec 06, 2024

Market Price of Mangalam Drugs and Organics Ltd

1M

1Y

3Y

5Y

Monitoring Mangalam Drugs and Organics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Dec 2024121
05 Dec 2024121.4
04 Dec 2024122.8
03 Dec 2024120
02 Dec 2024120.95
29 Nov 2024122.35
28 Nov 2024107.1
27 Nov 2024106.8
26 Nov 2024107
25 Nov 2024106.25

SWOT Analysis Of Mangalam Drugs and Organics Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Mangalam Drugs and Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Mangalam Drugs and Organics Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Mangalam Drugs and Organics Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Revenue of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical EBITDA of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Net Profit of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Dividend Payout of Mangalam Drugs and Organics Ltd

No data available

* All values are in %

About Mangalam Drugs and Organics Ltd

  • Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
  • The company was promoted by Dhoot family.
  • The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
  • The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

Mangalam Drugs and Organics Ltd News Hub

News

Mangalam Drugs and Organics reports standalone net profit of Rs 2.68 crore in the June 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.68 crore in the quarter ended J...

Read more

2024-08-14 00:00:00

News

Mangalam Drugs and Organics to declare Quarterly Result

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

2024-08-10 00:00:00

News

Mangalam Drugs and Organics AGM scheduled

Mangalam Drugs and Organics announced that the 51th Annual General Meeting (AGM) of the co...

Read more

2024-09-25 00:00:00

News

Mangalam Drugs and Organics to table results

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

2024-11-08 00:00:00

News

Mangalam Drugs and Organics reports standalone net profit of Rs 2.69 crore in the September 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.69 crore in the quarter ended S...

Read more

2024-11-15 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Mangalam Drugs and Organics Ltd

What is the current PE Ratio of Mangalam Drugs and Organics Ltd?

The Current PE Ratio of Mangalam Drugs and Organics Ltd is 20.37 as on 8 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 8 Dec 2024.

What was the PE Ratio of Mangalam Drugs and Organics Ltd last year?

The PE Ratio of Mangalam Drugs and Organics Ltd was 0.0 last year, now the PE ratio is 20.37, showing a year-on-year growth of -%.

What does the PE Ratio of Mangalam Drugs and Organics Ltd indicate about its stock?

The PE Ratio of Mangalam Drugs and Organics Ltd is 20.37. This ratio indicates that investors are willing to pay 20.37 times the earnings per share for each share of Mangalam Drugs and Organics Ltd.

What is the PE Ratio Growth of Mangalam Drugs and Organics Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Mangalam Drugs and Organics Ltd grew by -% whereas, the EPS ratio grew by 0.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions